ORGANOGENESIS HOLDINGS INC
NASDAQ: ORGO (Organogenesis Holdings Inc.)
Kemas kini terakhir: 2 hari lalu, 11:56PM5.15
0.03 (0.59%)
Penutupan Terdahulu | 5.12 |
Buka | 5.08 |
Jumlah Dagangan | 314,173 |
Purata Dagangan (3B) | 859,682 |
Modal Pasaran | 653,318,720 |
Harga / Jualan (P/S) | 1.40 |
Harga / Buku (P/B) | 2.54 |
Julat 52 Minggu | |
Tarikh Pendapatan | 7 Aug 2025 |
Margin Keuntungan | -3.46% |
Margin Operasi (TTM) | -23.28% |
EPS Cair (TTM) | -0.160 |
Pertumbuhan Hasil Suku Tahunan (YOY) | -21.20% |
Pertumbuhan Pendapatan Suku Tahunan (YOY) | 289.40% |
Jumlah Hutang/Ekuiti (D/E MRQ) | 11.58% |
Nisbah Semasa (MRQ) | 4.12 |
Aliran Tunai Operasi (OCF TTM) | 4.43 M |
Aliran Tunai Bebas Leveraj (LFCF TTM) | -4.36 M |
Pulangan Atas Aset (ROA TTM) | 0.70% |
Pulangan Atas Ekuiti (ROE TTM) | -4.92% |
Arah Aliran Pasaran
Jangka Pendek | Jangka Sederhana | ||
Industri | Drug Manufacturers - Specialty & Generic (US) | Menaik | Bercampur |
Drug Manufacturers - Specialty & Generic (Global) | Menaik | Bercampur | |
Stok | Organogenesis Holdings Inc. | Menaik | Menaik |
AISkor Stockmoo
Konsensus Penganalisis | 1.5 |
Aktiviti Orang Dalam | NA |
Volatiliti Harga | -1.5 |
Purata Bergerak Teknikal | 0.0 |
Osilator Teknikal | 4.0 |
Purata | 1.00 |
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. It has single operating segment which has regenerative medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others. |
|
Sektor | Healthcare |
Industri | Drug Manufacturers - Specialty & Generic |
Gaya Pelaburan | Small Core |
% Dimiliki oleh Orang Dalam | 46.49% |
% Dimiliki oleh Institusi | 54.09% |
Julat 52 Minggu | ||
Median | 9.00 (74.76%) | |
Jumlah | 1 Beli |
Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
---|---|---|---|---|
Cantor Fitzgerald | 08 Aug 2025 | 9.00 (74.76%) | Beli | 4.56 |
15 Jul 2025 | 7.00 (35.92%) | Beli | 4.03 |
Tiada data dalam julat masa ini.
Tarikh | Jenis | Butiran |
---|---|---|
27 Aug 2025 | Pengumuman | Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September |
07 Aug 2025 | Pengumuman | Organogenesis Holdings Inc. Reports Second Quarter 2025 Financial Results |
22 Jul 2025 | Pengumuman | Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2025 Financial Results on August 7, 2025 |
15 Jul 2025 | Pengumuman | Organogenesis Applauds CMS Proposal to Reform Skin Substitute Payment Policy; Urges Refinements to Ensure Patient Access to Appropriate Products and Continued Innovation |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
Keuntungan Nyata | - |
Keuntungan Tidak Nyata | - |
Dividen Diterima 2025 | - |
Jumlah Untung | - |
Pulangan Purata | - |
Kuantiti (Beli) | - |
Purata Harga (Beli) | - |
Kuantiti (Jual) | - |
Purata Harga (Jual) | - |